Employing the capacities of knowledge-based companies and Soha Pharmaceutical company, an MoU for developing medicines using new pharmaceutical technologies was signed between Presidency headquarter for biotechnology development and MPO.
According to the report of MPO's public
relations and international affairs unit citing from IRCS website, the joint session was held in the presence of
MPO's managing director, Staff Secretary of Presidency
headquarter for biotechnology development and senior officials of
knowledge-based companies.
At the beginning of the session, Dr.Askari lauded the knowledge-based companies
for their developments as well as technologies in the field of pharmaceutical industry
and said, "During my visit to the knowledge-based companies and accelerators I found out their outstanding scientific
progress and capabilities".